Aleksander Palkowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksander Palkowski has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Ajitha Rajan
School of Informatics, University of Edinburgh, Edinburgh, United Kingdom
72 shared publications - Alexander Laird
Department of Urology University of Edinburgh, Western General Hospital Edinburgh UK
72 shared publications - Catia Pesquita
LASIGE, Faculdade de Ciências da Universidade de Lisboa
72 shared publications - Christophe Battail
Universite Grenoble Alpes, CEA, INSERM, IRIG, UA13 BGE, Grenoble, France
72 shared publications - Fabio Massimo Zanzotto
University of Rome “Tor Vergata”, Rome, Italy
72 shared publications - Javier Antonio Alfaro
International Centre for Cancer Vaccine Science, University of Gdansk, Gdansk, Poland
72 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by MDPI AG in Preprints.org
Cough Sound Analysis in Gastroesophageal Reflux Disease: A Comparison of Popular Signal Analysis Methods Based on a Case Study
Gastroesophageal reflux disease (GERD) is one of the most commonly diagnosed gastrointestinal disorders. Moreover, symptoms of GERD may be confused with symptoms of some cardiovascular diseases. This paper presents an analysis of cough sounds recorded from a volunteer who suffers from GERD. The samples were collected at five different occasions, during which the proband showed different severity of GERD symptoms. The samples are analysed using the following popular signal analysis methods: short-time Fourier transform, total harmonic distortion, Hilbert transform, power spectrum and continuous wavelet transform. The results show that differentiation between different symptom loads of GERD by the sound of cough alone is possible after an appropriate cough waveform transformation.
- 10 August 2026
- Published by MDPI AG in Preprints.org
Open AccessCough Sound Analysis in Gastroesophageal Reflux Disease: A Comparison of Popular Signal Analysis Methods Based on a Case Study
Gastroesophageal reflux disease (GERD) is one of the most commonly diagnosed gastrointestinal disorders. Moreover, symptoms of GERD may be confused with symptoms of some cardiovascular diseases. This paper presents an analysis of cough sounds recorded from a volunteer who suffers from GERD. The samples were collected at five different occasions, during which the proband showed different severity of GERD symptoms. The samples are analysed using the following popular signal analysis methods: short-time Fourier transform, total harmonic distortion, Hilbert transform, power spectrum and continuous wavelet transform. The results show that differentiation between different symptom loads of GERD by the sound of cough alone is possible after an appropriate cough waveform transformation.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Comparison data of COD-dipp ncMAPs with 4 other studies.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Comparison data of COD-dipp ncMAPs with 4 other studies.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Datasets and samples considered in this study.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Datasets and samples considered in this study.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Supplementary Figures S1 to S7.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Supplementary Figures S1 to S7.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Legends for Supplementary tables, supplementary figures, and supplementary notes.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Legends for Supplementary tables, supplementary figures, and supplementary notes.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Annotation of the COD-dipp ncMAPs.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Annotation of the COD-dipp ncMAPs.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Mapping of ncMAPs to COSMIC frameshift mutations.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Mapping of ncMAPs to COSMIC frameshift mutations.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Open search peptide-spectrum matches (PSMs) information of serine acetylation, cysteinylation, carbamidomethylation, and cysteine trioxidation.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Open search peptide-spectrum matches (PSMs) information of serine acetylation, cysteinylation, carbamidomethylation, and cysteine trioxidation.
- Open Access
Expanding the definition of MHC Class I peptide binding promiscuity to support vaccine discovery across cancers with CARMEN
Promiscuity in T-cell antigen landscapes refers to the dual flexibility of peptides binding multiple MHC alleles and MHC alleles presenting diverse arrays of peptides. By understanding how neoantigens are shared across varied HLA backgrounds, promiscuity analysis can inform the selection of cancer-vaccine targets that reach a wider segment of the population and help refine patient stratification for diverse immunotherapies. We expand the concept of promiscuity to encompass peptides, MHC alleles, individuals, populations, and genomic regions. Our CARMEN database release harmonizes data from 72 publications (2,323 samples) across tissue types, with a focus on cancer. Using Gibbs clustering and dimensionality reduction (UMAP), we systematically map promiscuity and immunological versatility across these biological levels. Gene and mutation analysis reveals recurrent cancer mutations in highly promiscuous genomic regions, highly mutated cancer genes that avoid presented regions, and sheds light on genomic regions important to response to immunotherapy.
Open AccessExpanding the definition of MHC Class I peptide binding promiscuity to support vaccine discovery across cancers with CARMEN
Promiscuity in T-cell antigen landscapes refers to the dual flexibility of peptides binding multiple MHC alleles and MHC alleles presenting diverse arrays of peptides. By understanding how neoantigens are shared across varied HLA backgrounds, promiscuity analysis can inform the selection of cancer-vaccine targets that reach a wider segment of the population and help refine patient stratification for diverse immunotherapies. We expand the concept of promiscuity to encompass peptides, MHC alleles, individuals, populations, and genomic regions. Our CARMEN database release harmonizes data from 72 publications (2,323 samples) across tissue types, with a focus on cancer. Using Gibbs clustering and dimensionality reduction (UMAP), we systematically map promiscuity and immunological versatility across these biological levels. Gene and mutation analysis reveals recurrent cancer mutations in highly promiscuous genomic regions, highly mutated cancer genes that avoid presented regions, and sheds light on genomic regions important to response to immunotherapy.